abil
cell
act
cytolyt
effector
produc
shown
mediat
resist
toxoplasma
gondii
murin
model
due
recognit
peptid
restrict
murin
mhc
class
molecul
howev
gondii
specif
restrict
peptid
proven
protect
gondii
recent
two
gondiispecif
hlab
cell
epitop
lpqfataat
vpfvvflva
display
highaffin
bind
hlab
elicit
pbmc
seroposit
hlab
person
herein
peptid
evalu
determin
whether
could
elicit
splenocyt
hlab
transgen
mice
administ
adjuv
protect
subsequ
challeng
peptidespecif
produc
cell
identifi
elispot
prolifer
assay
util
splenic
lymphocyt
hla
transgen
mice
hlab
mice
immun
one
epitop
identifi
conjunct
univers
cell
epitop
padr
adjuv
cell
adjuv
glase
stimulatori
pam
cy
cell
immun
induc
cell
produc
protect
mice
high
parasit
burden
challeng
gondii
work
demonstr
feasibl
bioinformat
follow
empir
approach
base
hla
bind
test
biolog
activ
identifi
protect
hlab
restrict
gondii
peptid
adjuv
elicit
protect
immun
respons
hlab
mice
toxoplasma
gondii
intracellular
parasit
infect
broad
rang
mammalian
host
caus
sever
diseas
immunecompromis
immunolog
immatur
person
infect
caus
sever
ocular
neurolog
system
diseas
set
sinc
medicin
erad
life
cycl
stage
parasit
develop
vaccin
gondii
would
extrem
use
especi
vaccin
could
prevent
acquisit
parasit
complet
ideal
vaccin
protect
toxoplasmosi
human
would
includ
epitop
elicit
protect
biasedimmun
respons
character
gener
longliv
cell
cell
critic
role
protect
immun
gondii
murin
model
human
cell
interferon
gamma
signific
effector
mediat
resist
acut
chronic
gondii
infect
peptidebas
vaccin
deriv
cell
epitop
promis
strategi
mobil
immun
system
gondii
human
howev
gondii
specif
restrict
cell
epitop
proven
protect
identifi
previous
hpgsvnefdf
singl
decapeptid
deriv
dens
granul
protein
identifi
protect
immunodomin
l
restrict
epitop
mice
infect
type
ii
gondii
parasit
earlier
work
definit
proven
l
essenti
restrict
cyst
number
brain
patholog
l
mice
recent
studi
also
demonstr
immun
mice
lipopeptid
construct
padr
monophosphoryl
lipid
glase
protect
balbc
mice
howev
administ
transgen
mice
similar
manner
immunogen
despit
common
l
peptid
bind
motif
therefer
ore
order
find
effect
peptid
gondii
deriv
restrict
cell
util
bioinformat
algorithm
identifi
novel
gondiideriv
cell
epitop
restrict
supertyp
collect
provid
coverag
human
popul
worldwid
screen
amino
acid
sequenc
nine
surfac
secret
protein
type
ii
gondii
strain
hlab
peptid
bind
score
use
bioinformat
analysi
peripher
blood
mononuclear
cell
seroposit
seroneg
person
test
respons
peptid
use
elispot
assay
strikingli
two
gondiispecif
hlab
cell
epitop
one
deriv
lpqfataat
deriv
vpfvvflva
display
highaffin
bind
hlab
stimul
product
peripher
blood
cell
hlab
person
infect
gondii
seroneg
control
herein
evalu
peptid
identifi
earlier
use
bioinformat
vitro
analys
vaccin
compon
administ
conjunct
pan
dr
epitop
padr
univers
helper
lymphocyt
epitop
hlab
transgen
mice
immun
hlab
transgen
mice
peptid
lpqfataat
help
padr
glase
pam
cy
adjuv
activ
cell
produc
protect
subsequ
challeng
high
burden
type
ii
parasit
hlab
peptid
lpqfataat
vpfvvflva
padr
akfvaawtlkaaa
pam
cy
pam
kss
synthes
synthet
biomolecul
san
diego
puriti
lyophil
form
agonist
glase
mimet
synthes
infecti
diseas
research
institut
idri
seattl
wa
use
previous
describ
femal
hlab
transgen
mice
express
chimer
b
mhc
class
molecul
x
balbc
background
backcross
mani
gener
previous
describ
produc
pharmexaepimmun
san
diego
ca
bred
univers
chicago
hla
mice
also
util
experi
studi
conduct
approv
institut
anim
care
use
committe
univers
chicago
peptid
dissolv
pb
follow
brief
vortex
give
concentr
mgml
sampl
centrifug
rpm
room
temperatur
supernat
concentr
determin
measur
absorb
nm
hplc
percentag
solubl
sampl
calcul
although
detail
studi
optim
concentr
peptid
adjuv
perform
herein
hlab
mice
inocul
subcutan
sc
base
tail
use
needl
singl
peptid
mixtur
two
identifi
cell
peptid
amino
acid
sequenc
lpqfataat
amino
acid
sequenc
vpfvvflva
peptid
per
mous
without
padr
pam
cy
emulsifi
glase
agonist
control
mice
inject
pb
mice
boost
twice
interv
total
peptid
per
mous
immunogen
challeng
studi
mice
challeng
day
post
immun
peptid
emuls
via
intraperiton
ip
inocul
prugniauda
type
ii
strain
luciferas
express
parasit
experi
compar
treatment
pb
glase
padr
glase
padr
prugneaud
parasit
transfect
luciferas
produc
cyst
kindli
provid
laura
knoll
madison
wisconsin
use
challeng
mice
euthan
day
last
immun
spleen
harvest
press
screen
form
singlecel
suspens
deplet
erythrocyt
akc
lysi
buffer
nh
cl
khco
edta
cultur
prepar
separ
spleen
cell
individu
mous
cell
cultur
hour
describ
previous
murin
elispot
assay
perform
use
antimous
mab
biotinyl
antimous
mab
splenocyt
plate
per
well
antibodi
reagent
use
elispot
assay
obtain
mabtech
cincinnati
oh
cell
plate
least
replic
well
condit
result
express
number
spot
form
cell
sfc
per
murin
splenocyt
murin
splenocyt
incub
relev
block
antibodi
h
co
seed
cell
per
well
antibodi
biolegend
monoclon
antibodi
bd
bioscienc
relev
isotyp
control
rat
igg
bd
bioscienc
ad
sampl
final
concentr
assay
product
splenocyt
incub
bd
bioscienc
per
cell
min
wash
antihlab
biolegend
mab
isotyp
control
mous
igg
biolegend
ad
final
concentr
splenocyt
suspens
contain
cellsml
immun
mice
plate
ubottom
tissu
cultur
plate
per
well
along
stimul
dilut
appropri
concentr
complet
stimul
use
peptid
concanavalin
use
posit
control
cell
cultur
media
alon
use
neg
control
plate
incub
day
puls
h
thymidin
per
well
final
h
cell
harvest
onto
unifilt
plate
use
cell
harvest
packard
instrument
meriden
ct
dri
microscint
ad
well
filter
plate
seal
count
top
count
packard
instrument
determin
radioact
incorpor
dna
result
express
stimul
index
si
calcul
ratio
mean
count
per
minut
cpm
triplic
stimul
cultur
mean
count
per
min
triplic
unstimul
cultur
si
valu
greater
si
control
group
consid
signific
transgen
gondii
strain
use
vivo
challeng
deriv
type
ii
prugniaud
pru
strain
express
firefli
luciferas
fluc
gene
constitut
tachyzoit
bradyzoit
creat
maintain
util
previous
describ
mice
infect
prufluc
tachyzoit
imag
day
postchalleng
use
vivo
imag
system
ivi
xenogen
alameda
ca
previous
describ
briefli
mice
inject
ip
dluciferin
mgml
immedi
anesthet
rich
induct
chamber
isofluran
min
mice
imag
ventral
posit
photon
emiss
assess
use
live
softwar
xenogen
separ
compar
effect
immun
padreglas
versu
padreglasepeptid
imag
brain
ex
vivo
perform
day
fluc
prugneaud
strain
kindli
provid
laura
knoll
madison
wisconsin
challeng
mous
receiv
intraperiton
dose
microlit
dluciferin
minut
earlier
brain
remov
submerg
luciferin
imag
bioluminesc
data
present
pseudocolor
represent
light
intens
mean
photonssregion
interest
roi
quantit
assay
measur
bind
peptid
hla
class
molecul
base
inhibit
bind
radiolabel
standard
peptid
assay
perform
describ
previous
briefli
concentr
radiolabel
peptid
coincub
nm
concentr
purifi
mhc
presenc
human
microglubulin
day
bind
radiolabel
peptid
correspond
mhc
class
molecul
determin
captur
mhcpeptid
complex
greiner
lumitrac
micropl
coat
antibodi
bound
count
per
minut
measur
use
topcount
microscintil
counter
concentr
peptid
yield
inhibit
bind
radiolabel
probe
peptid
mice
per
group
pbmc
obtain
seroposit
seroneg
donor
experi
repeat
least
twice
statist
analys
vitro
assay
perform
use
student
ttest
twotail
p
valu
consid
statist
signific
peptid
consid
immunogen
mice
induc
spot
format
prolifer
si
immun
mice
signific
p
compar
spot
format
control
mice
address
capac
two
identifi
epitop
lpqfataat
vpfvvflva
prime
respons
transgen
mice
immun
sc
peptid
alon
peptid
padr
peptid
padr
pam
cy
regent
mix
glase
mixtur
two
peptid
padr
plu
pam
cy
mix
glase
also
use
immunogen
shown
fig
littl
respons
observ
follow
immun
peptid
mix
glase
alon
padr
ad
immun
signific
amount
produc
follow
stimul
one
epitop
peptid
lpqfataat
vitro
compar
peptid
mix
glase
alon
even
robust
respons
achiev
pam
cy
ad
immunogen
contrast
signific
amount
produc
use
splenocyt
group
immun
anoth
epitop
peptid
vpfvvflva
p
compar
control
group
stimul
peptid
separ
experi
immun
mice
glase
plu
padr
elicit
splenocyt
test
without
peptid
background
detail
experi
report
previous
similar
result
found
peptid
pool
immun
splenocyt
mice
immun
mixtur
two
peptid
padr
plu
pam
cy
mix
glase
produc
signific
amount
stimul
p
compar
pb
immun
group
p
compar
pb
immun
group
fig
assess
rel
contribut
cell
overal
respons
activ
splenic
cell
block
use
antibodi
specif
cell
receptor
spot
format
significantli
reduc
presenc
incub
spleen
cell
mice
immun
includ
vaccin
stimul
fig
correl
solubl
peptid
immunogen
summar
tabl
much
less
solubl
overal
percent
solubl
contrast
solubl
effect
peptid
vaccin
construct
reduc
solubl
peptid
vaccin
correl
reduc
immunogen
log
differ
solubl
ineffect
much
less
solubl
effect
much
solubl
peptid
prepar
solubl
mgml
solubl
r
valu
standard
curv
respect
sinc
peptid
formul
vaccin
hlab
transgen
mice
could
effect
elicit
cell
produc
peptid
formul
evalu
protect
transgen
mice
subsequ
studi
abil
glase
pam
cy
adjuv
peptid
also
evalu
mice
immun
peptid
alon
padreglasepam
cy
shown
fig
immun
alon
induc
effect
product
padr
helper
epitop
includ
immunogen
induc
small
amount
signific
compar
peptid
alon
glase
ad
robust
cell
product
achiev
compar
peptid
alon
compar
peptidepadr
greater
respons
observ
pam
cy
ad
vaccin
compar
peptid
alon
compar
peptidepadr
compar
peptidepadreglas
howev
addit
pam
cy
padreglas
significantli
enhanc
ltp
specif
respons
thu
glase
effect
adjuv
enhanc
product
respons
cell
elicit
peptid
hlab
transgen
mice
prolif
respons
fig
si
observ
follow
immun
cy
peptid
epitop
use
alon
immun
si
fig
magnitud
lymphocyt
blastogenesi
elicit
adjuv
pattern
fig
b
order
determin
function
cell
epitop
padr
peptid
vaccin
padrespecif
cell
respons
evalu
elispot
assay
prolif
respons
assay
use
splenocyt
immun
mice
shown
fig
immun
cell
epitop
alon
induc
respons
wherea
cell
epitop
padr
ad
immunogen
cell
could
activ
secret
compar
pb
group
compar
peptid
alon
immun
group
prolif
respons
si
observ
follow
immun
plu
padr
pam
cy
glase
howev
block
cell
receptor
use
antibodi
significantli
reduc
product
fig
thu
indic
padr
effect
th
epitop
contribut
peptid
vaccin
construct
howev
instanc
eg
padr
elicit
small
enhanc
respons
splenocyt
isol
peptideimmun
transgen
mice
day
immun
incub
antibodi
common
isotyp
control
prior
stimul
abil
gener
lymphocyt
prolifer
respons
peptid
test
studi
abil
block
respons
cell
experi
block
cell
block
use
spleen
cell
experi
data
fig
b
show
block
cell
receptor
use
antibodi
significantli
reduc
product
cell
prolifer
p
fig
analyz
associ
present
hlab
block
experi
use
monoclon
antihlab
antibodi
perform
result
indic
secret
significantli
decreas
antibodi
control
antibodi
p
fig
result
demonstr
peptid
specif
respons
hlab
restrict
involv
cell
partial
block
hla
antibodi
like
function
antibodi
capac
block
reactiv
peptid
murin
haplotyp
algorithm
predict
poor
affin
background
balbc
molecul
peptid
use
iedb
predict
peptid
predict
bind
poorli
molecul
tabl
hlab
transgen
mice
immun
peptid
plu
padr
pam
cy
glase
three
time
two
week
interv
mice
challeng
week
last
immun
imag
day
postchalleng
pru
fluc
use
xenogen
vivo
imag
system
shown
repres
experi
figur
number
luciferas
express
parasit
immun
hlab
mice
significantli
reduc
compar
number
parasit
unimmun
mice
figur
also
signific
reduct
cyst
brain
mice
immun
peptid
vaccin
figur
reduct
mean
cyst
per
brain
separ
experi
perform
immun
glase
padr
compar
experi
consist
result
splenocyt
produc
experi
challeng
fluc
parasit
demonstr
protect
glasepadr
anoth
strain
transgen
mous
hla
also
use
confirm
glase
padr
neither
elicit
protect
anoth
strain
hla
transgen
mous
tabl
found
mice
brain
luminesc
less
peptidepadreglas
group
p
less
padreglas
group
p
herein
two
gondiispecif
hlab
restrict
cell
epitop
lpqfataat
vpfvvflva
deriv
elicit
human
pbmc
cell
seroposit
seroneg
person
upon
immun
mice
lpqfataat
elicit
cell
specif
help
univers
epitop
adjuv
glase
pam
cy
enhanc
respons
peptid
vaccin
plu
adjuv
protect
transgen
mice
type
ii
parasit
challeng
cell
epitop
identifi
dens
granul
gra
protein
toxoplasma
gondii
mani
studi
shown
dens
granul
antigen
gra
involv
parasit
surviv
virul
protein
secret
abund
circul
blood
stream
first
hour
follow
infect
appear
day
mice
infect
parasit
gra
protein
thu
consid
attract
vaccin
candid
prevent
control
toxoplasmosi
two
peptid
recogn
cell
gondii
specif
restrict
pbmc
howev
although
peptid
vpfvvflva
recogn
cell
toxoplasma
gondiispecif
human
pbmc
induc
signific
respons
hlab
transgen
mice
therefor
conclud
present
supertyp
molecul
cell
human
present
signific
quantiti
present
supertyp
molecul
cell
transgen
mice
specul
seem
like
due
rel
insolubl
peptid
although
differ
formul
could
also
explain
result
peptid
insolubl
overal
percent
solubl
pb
contrast
solubl
solubl
pb
effect
peptid
vaccin
construct
va
reduc
solubl
peptid
vaccin
peptid
might
correl
reduc
immunogen
inclus
padr
synthet
nonnatur
pan
hla
dr
bind
epitop
peptid
bind
promiscu
variant
human
mhc
class
ii
molecul
dr
effect
human
hla
transgen
mice
augment
cell
effector
function
induc
helper
cell
padr
epitop
demonstr
deliv
help
mhc
class
restrict
peptidespecif
ctl
respons
gondii
peptid
herein
requir
cell
help
gener
cell
respons
also
prove
viral
bacteri
parasit
model
studi
trypanosoma
cruzi
infect
demonstr
cell
help
requir
primari
respons
immunodomin
epitop
result
suggest
vaccin
epitop
target
order
drive
protect
immun
respons
although
peptid
vaccin
includ
epitop
could
prime
cellmedi
immun
respons
lowmolecularweight
synthet
peptid
antigen
highli
immunogen
observ
led
investig
coadminist
addit
known
adjuv
vaccin
antigen
potenti
activ
vaccin
weak
immunogen
synthet
epitop
adjuv
antigen
contribut
success
vaccin
exampl
monophosphoryl
lipid
mla
detoxifi
deriv
lipopolysaccharid
lp
salmonella
minesota
tolllik
receptor
agonist
thu
potent
activ
respons
use
adjuv
human
vaccin
trial
sever
infecti
diseas
cancer
effect
adjuv
provid
cell
help
immun
protozoan
infect
leishmaniasi
studi
robust
respons
observ
glase
includ
prepar
immun
mice
pam
cy
palmitoyloxi
propyl
cystein
lipid
compon
macrophageactiv
lipopeptid
pam
cy
bind
activ
dendrit
cell
engag
tolllik
receptor
tolllik
receptor
tlr
function
patternrecognit
receptor
mammal
suggest
receptor
might
particip
host
defens
gondii
infect
activ
gpi
could
work
togeth
receptor
like
tlr
obtain
effect
host
respons
gondii
infect
studi
even
robust
respons
observ
pam
cy
coadministr
group
robust
protect
achiev
transgen
mice
challeng
type
ii
parasit
follow
immun
background
mice
multigener
backcross
mice
balbk
mice
compar
mice
without
transgen
work
present
herein
indic
restrict
epitop
lpqfataat
deriv
elicit
cell
seroposit
person
elicit
cell
administ
univers
dr
epitop
padr
help
glase
pam
cy
adjuv
mhc
class
irestrict
cell
peptid
vaccin
reduc
parasit
burden
immun
mice
challeng
type
ii
parasit
knowledg
first
report
gondii
specif
restrict
cell
epitop
base
vaccin
protect
transgen
mice
gondii
find
facilit
develop
immunosens
ie
base
bioinformat
follow
empir
test
approach
base
hla
bind
effect
human
cell
vitro
test
hla
transgen
mice
epitopebas
vaccin
human
use
refer
web
version
pubm
central
supplementari
materi
lpqfataat
vpfvvflva
prepar
follow
peptid
alon
peptid
plu
padr
peptid
plu
padr
pam
cy
immunogen
mix
glase
immun
given
three
time
two
week
interv
day
last
immun
spleen
cell
obtain
immun
mice
stimul
specifi
peptid
ex
vivo
elispot
assay
experi
perform
time
b
hlab
mice
immun
peptid
pool
test
recal
respons
padr
hlab
transgen
mice
immun
mixtur
two
identifi
peptid
padr
pam
cy
mix
glase
three
time
two
week
interv
fourteen
day
last
immun
spleen
remov
immun
mice
splenocyt
cultur
peptid
padr
result
express
spot
format
one
million
cell
data
present
repres
exampl
three
independ
experi
c
spot
format
significantli
reduc
presenc
antibodi
splenocyt
immun
mice
incub
antibodi
isotyp
control
min
prior
stimul
p
p
spot
format
test
splenocyt
mice
receiv
differ
vaccin
formul
absenc
presenc
block
antibodi
b
padrespecif
spot
format
spleen
cell
prolifer
test
splenocyt
formul
immun
mice
expos
padr
peptid
p
p
c
block
cell
receptor
use
ab
signific
decreas
product
follow
group
respons
lymphocyt
prolifer
measur
block
b
c
splenocyt
isol
peptideimmun
transgen
mice
day
immun
incub
antibodi
common
isotyp
control
min
prior
stimul
abil
gener
lymphocyt
prolifer
respons
peptid
test
p
p
figur
xenogen
imag
brain
ex
vivo
follow
inject
luciferin
intraperiton
exposur
brain
luciferin
solut
twenti
one
day
earlier
mice
challeng
fluc
prugneaud
parasit
appear
ill
receiv
three
dose
howev
receiv
three
dose
pb
three
dose
glasepadr
appear
ill
day
challeng
mice
per
treatment
group
fluc
challeng
follow
immun
week
neither
glasepadr
pb
elicit
splenocyt
produc
restimul
wherea
immun
data
shown
also
shown
hla
transgen
mous
strain
tabl
neither
pb
glasepadr
led
decreas
lucifereas
detet
tabl
correl
solubl
peptid
immunogen
peptid
bind
affin
hlab
predict
use
arb
algorithm
immunoepitop
databas
iedb
ic
inhibit
bind
competitor
bind
affin
perform
mhc
bind
assay
percent
solubl
valu
determin
absorb
bradford
assay
pbmc
cell
four
gondiiseroposit
human
three
seroneg
one
stimul
lpqfataat
vpfvvflva
cell
produc
test
elispot
assay
splenic
cell
isol
hlaa
mice
week
peptid
immun
test
abil
gener
respons
peptid
immunogen
dose
